Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly...

por Kern, Silke, Skoog, Ingmar, Östling, Svante, Kern, Jürgen, Börjesson-Hanson, Anne
Publicado 2012

Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds

por Fässberg, Madeleine Mellqvist, Östling, Svante, Börjesson-Hanson, Anne, Skoog, Ingmar, Wærn, Margda
Publicado 2013

Decreasing prevalence of dementia in 85-year olds examined 22 years apart: the influence of education and stroke

por Skoog, Ingmar, Börjesson-Hanson, Anne, Kern, Silke, Johansson, Lena, Falk, Hanna, Sigström, Robert, Östling, Svante
Publicado 2017

Low Cerebrospinal Fluid Aβ(42) and Aβ(40) are Related to White Matter Lesions in Cognitively Normal Elderly

por Skoog, Ingmar, Kern, Silke, Zetterberg, Henrik, Östling, Svante, Börjesson-Hanson, Anne, Guo, Xinxin, Blennow, Kaj
Publicado 2018

Prevalence of preclinical Alzheimer disease: Comparison of current classification systems

por Kern, Silke, Zetterberg, Henrik, Kern, Jürgen, Zettergren, Anna, Waern, Margda, Höglund, Kina, Andreasson, Ulf, Wetterberg, Hanna, Börjesson-Hanson, Anne, Blennow, Kaj, Skoog, Ingmar
Publicado 2018

Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study

por Landen, Jaren W., Andreasen, Niels, Cronenberger, Carol L., Schwartz, Pamela F., Börjesson-Hanson, Anne, Östlund, Henrik, Sattler, Catherine A., Binneman, Brendon, Bednar, Martin M.
Publicado 2017

Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases

por Craggs, Lucinda, Taylor, Julie, Slade, Janet Y., Chen, Aiqing, Hagel, Christian, Kuhlenbaeumer, Gregor, Borjesson‐Hanson, Anne, Viitanen, Matti, Kalimo, Hannu, Deramecourt, Vincent, Oakley, Arthur E., Kalaria, Raj N.
Publicado 2015

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial

por Abdullah, Laila, Crawford, Fiona, Tsolaki, Magda, Börjesson-Hanson, Anne, Olde Rikkert, Marcel, Pasquier, Florence, Wallin, Anders, Kennelly, Sean, Ait-Ghezala, Ghania, Paris, Daniel, Hendrix, Suzanne, Blennow, Kaj, Lawlor, Brian, Mullan, Michael
Publicado 2020

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study

por Timmers, Maarten, Streffer, Johannes Rolf, Russu, Alberto, Tominaga, Yushin, Shimizu, Hiroko, Shiraishi, Ayako, Tatikola, Kanaka, Smekens, Pascale, Börjesson-Hanson, Anne, Andreasen, Niels, Matias-Guiu, Jorge, Baquero, Miquel, Boada, Mercè, Tesseur, Ina, Tritsmans, Luc, Van Nueten, Luc, Engelborghs, Sebastiaan
Publicado 2018

A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter

por LaBarbera, Kelsie M., Sheline, Yvette I., Izzo, Nicholas J., Yuede, Carla M., Waybright, Lora, Yurko, Raymond, Edwards, Hannah M., Gardiner, Woodrow D., Blennow, Kaj, Zetterberg, Henrik, Börjesson-Hanson, Anne, Morgan, Roger, Davis, Charles S., Guttendorf, Robert J., Schneider, Lon S., DeKosky, Steven, LeVine, Harry, Grundman, Michael, Caggiano, Anthony O., Cirrito, John R., Catalano, Susan M., Hamby, Mary E.
Publicado 2023

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease—the substudy protocols: NILVAD frailty; NILVAD blood and genetic b...

por Meulenbroek, Olga, O'Dwyer, Sarah, de Jong, Daan, van Spijker, Gerrita, Kennelly, Sean, Cregg, Fiona, Olde Rikkert, Marcel, Abdullah, Laila, Wallin, Anders, Walsh, Cathal, Coen, Robert, Kenny, Rose Anne, Daly, Leslie, Segurado, Ricardo, Borjesson-Hanson, Anne, Crawford, Fiona, Mullan, Michael, Lucca, Ugo, Banzi, Rita, Pasquier, Florence, Breuilh, Laetitia, Riepe, Matthias, Kalman, Janos, Molloy, William, Tsolaki, Magda, Howard, Robert, Adams, Jessica, Gaynor, Siobhan, Lawlor, Brian
Publicado 2016

Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial

por Mummery, Catherine J., Börjesson-Hanson, Anne, Blackburn, Daniel J., Vijverberg, Everard G. B., De Deyn, Peter Paul, Ducharme, Simon, Jonsson, Michael, Schneider, Anja, Rinne, Juha O., Ludolph, Albert C., Bodenschatz, Ralf, Kordasiewicz, Holly, Swayze, Eric E., Fitzsimmons, Bethany, Mignon, Laurence, Moore, Katrina M., Yun, Chris, Baumann, Tiffany, Li, Dan, Norris, Daniel A., Crean, Rebecca, Graham, Danielle L., Huang, Ellen, Ratti, Elena, Bennett, C. Frank, Junge, Candice, Lane, Roger M.
Publicado 2023

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

por Lawlor, Brian, Segurado, Ricardo, Kennelly, Sean, Olde Rikkert, Marcel G. M., Howard, Robert, Pasquier, Florence, Börjesson-Hanson, Anne, Tsolaki, Magda, Lucca, Ugo, Molloy, D. William, Coen, Robert, Riepe, Matthias W., Kálmán, János, Kenny, Rose Anne, Cregg, Fiona, O'Dwyer, Sarah, Walsh, Cathal, Adams, Jessica, Banzi, Rita, Breuilh, Laetitia, Daly, Leslie, Hendrix, Suzanne, Aisen, Paul, Gaynor, Siobhan, Sheikhi, Ali, Taekema, Diana G., Verhey, Frans R., Nemni, Raffaello, Nobili, Flavio, Franceschi, Massimo, Frisoni, Giovanni, Zanetti, Orazio, Konsta, Anastasia, Anastasios, Orologas, Nenopoulou, Styliani, Tsolaki-Tagaraki, Fani, Pakaski, Magdolna, Dereeper, Olivier, de la Sayette, Vincent, Sénéchal, Olivier, Lavenu, Isabelle, Devendeville, Agnès, Calais, Gauthier, Crawford, Fiona, Mullan, Michael
Publicado 2018